6th CACHEXIA CONFERENCEのプログラム

12月5-7日に神戸で開催される6th CACHEXIA CONFERENCEのプログラムがHPに掲載されています。

http://www.lms-events.com/19/index.php

まだすべてのプログラムが掲載されているわけではありませんが、概要は十分わかります。2日目はClinical trackとBasic trackに分かれていて、臨床研究者向けと基礎研究者向けにそれぞれプログラムがあるようです。私はもちろん臨床研究者向けのプログラムに参加しようと考えています。以下、プログラムを引用掲載します。

Day 1 Monday, 5 December 2011

12:15-13:15 Lunch seminars

13:30-15.30

OPENING SESSION:

1. “Prometheus” basic science key note lecture:
Cachexia as an energy wasting syndrome
2. Ghrelin – Important hormone and treatment option for cachexia
3. Accelerated loss of muscle in elderly people with inactivity
4. How to measure undernutrition
5. From sarcopenia to frailty

15:30-16:00 Coffee break

16:00-17:45

PLENARY SESSION:

6. “Hippocrates” clinical science key note lecture:
Sarcopenia vs. osteopenia/osteroporosis
7. Update from Trialist Workshop 2010: cancer cachexia
8. Update from Trialist Workshop 2010: sarcopenia definition
9. Influence of muscle wasting on outcomes in the Western World
10. Influence of muscle wasting on outcomes in Japan

Day 2 Tuesday, 6 December 2011

8:30-10:00

Clinical track: Sarcopenia & weight loss

11. Chronobiological considerations regarding the diagnosis, treatment and regulatory evaluation of cachexia & sarcopenia
12. Ultrasound measurement of muscle quality and quantity
13. Sarcopenia and frailty in the Orient
14. Managing weight loss: the nursing viewpoint
15. Weight loss and aging

8:30-10:00

Basic track: Regulation of muscle wasting

16. Molecular control of atrophy in senescent muscle
17. Nutritional control of muscle atrophy: role of branched chain amino acids
18. Muscle wasting and sepsis: Data from the intensive care unit
19. Role of beta-adrenergic signaling in skeletal muscle structure and function: implications for muscle wasting and disease
20. Role of micro RNA’s

10:00-11:00 Coffee break and poster session 1

11:00-12:30

Basic track: Cancer cachexia

21. Review on animal models for cancer cachexia
22. Recent advances in the biology of muscle wasting
23. Myostatin as target – update 2011
24. Follistatin as a target for anabolic therapies
25. Intra-myocellular fat as a determinate of poor functional status

11:00-12:30

Clinical track: Effects of herbal therapy in cachexia

26. Japanese herbal medicine – an overview
27. Herbal medicine for cachexia
28. Immune therapy
29. Cachexia in Vietnam and traditional therapies

12:45-13:45 Lunch seminars

14:00-15:30

Clinical Track: Update on anabolics & related therapies

30. Biomarkers for muscle wasting and cachexia
31. New therapies for cachexia / sarcopenia
32. Testosterone, sarcopenia and frailty
33. SARMS
34. Ghrelin trial update
35. ACTAs

Panel discussion

14:00-15:30

Basic track: Exercise therapy & Psychosomatic aspects

36. Depression & body weight – importance for sarcopenia and cachexia
37. Palliative care for cachexia in Japan
38. Palliative care for cancer & cachexia – survival impact
39. Pain and cachexia
40. Exercise, quality of life & cachexia therapy

15:30-16:30 Coffee break and poster session 2

16:30-18:00

Clinical track: Late breaking clinical trials

41. Regulatory considerations for treatment development in cachexia & sarcopenia
42. - 47. (To be confirmed)

16:30-18:00

JUDGES’ CHOICE: Basic science

48. Pancreatic cancer and ghrelin
49. Muscle phenotype shift and wasting in stroke
50. - 53. (To be confirmed)

Day 3 Wednesday, 7 December 2011

8:00-9:30

Young investigators Award Session – Clinical & Basic

54. - 59 (Finalists: 2 abstracts clinical / 2 abstracts basic / 2 abstracts nutritional issues

8:00-9:30

Clinical & basic track:

60. Peptide autoantibodies
61. IGF-1 update 2011
62. GDF-15 alias MIC-1 and tissue wasting
63. Cachexia in acute illness and viruses
64. Diabetes and muscle wasting

9:30-10:30 Coffee break and poster session 3

10:30-12:00

JUDGES’ CHOICE: Clinical & nutrition science

65. - 70. ( 6 abstracts to be selected)

10:30-12:00

Basic track: Symptoms / Neuroscience

71. Neuropeptides and Cachexia
72. PTHrP and Cachexia
73. Role of change in neuromuscular junction: Agrin and neurotrypsin in muscle wasting
74. Sensor control of cancer cachexia
75. Symptoms and symptom generation in cachexia

12:15-13:15 Lunch seminars

13:30-14:45

PLENARY SESSION:

Debate: Kobe beef or Belgium Blue: A continuing question?

76. Pro Belgian Blue
77. Pro Kobe Beef
78. Nutrition and inflammation
79. Cachexia and cardio-renal-anemia syndrome
80. “Highlights from our journal – editor’s choice”

14:45-15:15 Coffee break

15:15-16:30

PLENARY SESSION: Congress Highlights

81. Basic Science
82. Sarcopenia
83. Nutritional Therapies
84. Treatment of cachexia

Awards Ceremony